A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.

Clinical trial NCT03479307 · COMPLETED

Trial details

NCT number: NCT03479307
Sponsor: Faes Farma, S.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2018-04-07
Primary completion: 2018-08-09
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.